SLC2A4 expression and its epigenetic regulation as biomarkers for insulin resistance treatment in diabetes mellitus.

SLC2A4 expression and its epigenetic regulation as biomarkers for insulin resistance treatment in diabetes mellitus. Biomark Med. 2020 Apr 06;: Authors: Esteves JV, Yonamine CY, Machado UF PMID: 32250156 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research